SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Molly A. Holman, Ph.D., J.D. has joined the Company as Vice President of Intellectual Property. Dr. Holman has extensive scientific, legal and industry experience in the biotechnology and pharmaceutical fields.
